Qualigen Therapeutics | DEFA14A: Others
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | DEF 14A: Definitive information statements
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Qualigen Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Qualigen Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | 8-K: Current report
Qualigen Therapeutics | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Qualigen Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Qualigen Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
No Data
No Data